<DOC>
	<DOC>NCT01511159</DOC>
	<brief_summary>This trial is conducted in Europe. The aim of this trial is to determine the relative bioavailability of NNC 90-1170 (liraglutide) when inhaled compared to NNC 90-1170 when injected under the skin.</brief_summary>
	<brief_title>Comparison of Liraglutide Inhaled Into the Lungs Compared to Liraglutide Injected Under the Skin in Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>No clinically important abnormal physical findings No clinically relevant abnormalities in the results of laboratory screening evaluation Normal (or abnormal but not clinically significant) ECG (electrocardiogram) Normal (or abnormal but not clinically significant) blood pressure and heart rate Body Mass Index (BMI) between 2030 kg/m^2 or outwith range but not clinically significant Nonsmoker Forced Vital Capacity (FVC) and Forced Expiratory Volume in 1 second (FEV1) at least 85% of predicted normal for age, gender and height FVC ratio at least 75% of predicted normal for age, gender and height A clinically significant illness or infection requiring treatment within the last two months Any infection involving the respiratory system or adverse event that may, in the opinion of the principal investigator, interfere with blood glucose homeostasis Subjects with first and/or second degree relative(s) with diabetes mellitus Donation or loss of greater than 500 ml of blood in the period 012 weeks before trial entry Alcohol use in excess of 28 units of alcohol per week. A unit of alcohol is equivalent to half a pint of average strength beer, a glass (125 ml) of wine or a pub measure (25 ml) of spirits, sherry or port Current addiction to alcohol or substances of abuse Females Presence of hepatitis B surface antigen, hepatitis C antibody or HIV (human immunodeficiency virus) 1 or 2 antibodies</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>